Celiac Disease Treatment Market Trends And Growth Drivers Point To Strong Future Potential
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Celiac Disease Treatment Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The celiac disease treatment market has experienced notable expansion in recent years. Projected to rise from $0.66 billion in 2025 to $0.72 billion in 2026, with a compound annual growth rate of 9.3%, this upward trajectory reflects several key factors from the past period. These include a scarcity of pharmacological treatment choices, dependence on managing the condition through a gluten-free diet, higher diagnosis frequencies, growing public understanding of autoimmune diseases, and broader accessibility to diagnostic testing.
The celiac disease treatment market is projected to experience substantial expansion in the coming years. By 2030, it is anticipated to reach a value of $1.03 billion, with a compound annual growth rate (CAGR) of 9.2%. Factors driving this forecasted growth include the emergence of non-dietary treatment alternatives, progress in enzyme and immunotherapy research, a rising worldwide incidence of celiac disease, enhanced diagnostic precision, and greater healthcare investment in chronic autoimmune conditions. Key developments shaping the future include the growing preference for gluten-free dietary approaches, intensified efforts to create enzyme-based treatments, heightened emphasis on early detection and screening, the proliferation of nutritional supplement-based interventions, and growing patient awareness along with improved screening practices.
Download A Free Sample Report For Comprehensive Market Insights:
Celiac Disease Treatment Market Industry Drivers: What Is Driving Revenue Growth?
The anticipated expansion of the celiac disease treatment market is set to be driven by the growing prevalence of diabetes. Diabetes, a chronic health condition, involves the body’s inability to properly regulate blood sugar or glucose levels. The increasing number of diabetes cases can be attributed to overlapping dietary requirements, since both diabetes and celiac disease demand strict control over food consumption to stabilize blood glucose and avoid adverse effects. Celiac disease interventions support diabetes management by encouraging a gluten-free diet, which enhances digestive health and nutrient uptake. This leads to improved blood sugar regulation and reduced risk of complications for those managing both diseases. In June 2024, the National Health Service, a UK government department, reported that approximately 3,615,330 individuals registered with a general practitioner in 2023 had a diagnosis of non-diabetic hyperglycemia or pre-diabetes, representing an 18% rise from 3,065,825 cases recorded in 2022. Consequently, the increase in diabetes prevalence is fueling the celiac disease treatment market’s growth.
Celiac Disease Treatment Market Segment Landscape And Growth Potential
The celiac disease treatment market covered in this report is segmented –
1) By Treatment Type: Vitamins And Minerals, Gluten Degrading Enzymes, Symptomatic Treatment, Other Treatments
2) By Diagnosis: Serological Tests, Genetic Testing, Biopsy
3) By Distribution Channel: Hospitals, Research Centres, Clinics, Other Distribution Channels
Subsegments:
1) By Vitamins and Minerals: Iron Supplements, Calcium Supplements, Vitamin D, Vitamin B12, Multivitamins
2) By Gluten Degrading Enzymes: Endopeptidases, Exopeptidases, Combination Enzyme Formulations
3) By Symptomatic Treatment: Antidiarrheal Medications, Antidepressants, Anti-inflammatory Drugs, Immunosuppressive Agents
4) By Other Treatments: Probiotics, Immunotherapy, Experimental Therapies
Celiac Disease Treatment Market Growth Trends: What Is Influencing The Future Outlook?
Leading companies within the celiac disease treatment sector are concentrating their efforts on the development of oral therapies, particularly small molecule treatments, designed to achieve targeted relief through the blockade of immune responses triggered by gluten. This approach is intended to improve patient adherence by offering a viable alternative to the strict adherence required by gluten-free diets. Small molecule therapies are pharmaceutical agents of minute size capable of easily penetrating cells to precisely target and treat proteins or enzymes responsible for disease causation. As an example, in February 2025, Immunic Inc., a biotechnology firm based in the United States, introduced IMU-856. This specific small molecule elevates levels of endogenous glucagon-like peptide-1 (GLP-1), thereby enhancing intestinal barrier function in individuals with celiac disease. Additionally, IMU-856 facilitates improved nutrient absorption and alleviates symptoms, all while avoiding the suppression of immune activity.
Celiac Disease Treatment Market Competitive Landscape: Who Are The Leading Companies?
Major companies operating in the celiac disease treatment market are Pfizer Inc., Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceuticals Company Ltd., Amgen Inc., General Mills Inc., Viatris Inc., Teva Pharmaceutical Inc., Nestlé Health Science, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Pharmaceuticals Inc., Glenmark Pharmaceuticals Company Ltd., West-Ward Pharmaceuticals Company Ltd, Innovate Biopharmaceutical, Acto Biosciences, ImmunogenX
Access The Complete Celiac Disease Treatment Market Report:
Celiac Disease Treatment Market Largest Region: Which Geography Holds The Highest Market Share?
North America was the largest region in the celiac disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
